AAAAAA

   
Results: 1-19 |
Results: 19
INDUCTION OF NEUTRALIZING ANTIBODIES TO T-CELL LINE-ADAPTED AND PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES WITH A PRIME-BOOST VACCINE REGIMEN IN CHIMPANZEES
Authors: ZOLLAPAZNER S LUBECK M XU S BURDA S NATUK RJ SINANGIL F STEIMER K GALLO RC EICHBERG JW MATTHEWS T ROBERTGUROFF M
Citation: S. Zollapazner et al., INDUCTION OF NEUTRALIZING ANTIBODIES TO T-CELL LINE-ADAPTED AND PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES WITH A PRIME-BOOST VACCINE REGIMEN IN CHIMPANZEES, Journal of virology, 72(2), 1998, pp. 1052-1059
LONG-TERM PROTECTION OF CHIMPANZEES AGAINST HIGH-DOSE HIV-1 CHALLENGEINDUCED BY IMMUNIZATION
Authors: LUBECK MD NATUK R MYAGKIKH M KALYAN N ALDRICH K SINANGIL F ALIPANAH S MURTHY SCS CHANDA PK NIGIDA SM MARKHAM PD ZOLLAPAZNER S STEIMER K WADE M REITZ MS ARTHUR LO MIZUTANI S DAVIS A HUNG PP GALLO RC EICHBERG J ROBERTGUROFF M
Citation: Md. Lubeck et al., LONG-TERM PROTECTION OF CHIMPANZEES AGAINST HIGH-DOSE HIV-1 CHALLENGEINDUCED BY IMMUNIZATION, Nature medicine, 3(6), 1997, pp. 651-658
ENHANCEMENT OF IMMUNODEFICIENCY VIRUS-SPECIFIC IMMUNE-RESPONSES IN DNA-IMMUNIZED RHESUS MACAQUES
Authors: FULLER DH CORB MM BARNETT S STEIMER K HAYNES JR
Citation: Dh. Fuller et al., ENHANCEMENT OF IMMUNODEFICIENCY VIRUS-SPECIFIC IMMUNE-RESPONSES IN DNA-IMMUNIZED RHESUS MACAQUES, Vaccine, 15(8), 1997, pp. 924-926
NEUTRALIZATION OF A CLADE-B PRIMARY ISOLATE BY SERA FROM HUMAN-IMMUNODEFICIENCY-VIRUS-UNINFECTED RECIPIENTS OF CANDIDATE AIDS VACCINES
Authors: ZOLLAPAZNER S ALVING C BELSHE R BERMAN P BURDA S CHIGURUPATI P CLEMENTS ML DULIEGE AM EXCLER JL HIOE C KAHN J MCELRATH MJ SHARPE S SINANGIL F STEIMER K WALKER MC WASSEF N XU S
Citation: S. Zollapazner et al., NEUTRALIZATION OF A CLADE-B PRIMARY ISOLATE BY SERA FROM HUMAN-IMMUNODEFICIENCY-VIRUS-UNINFECTED RECIPIENTS OF CANDIDATE AIDS VACCINES, The Journal of infectious diseases, 175(4), 1997, pp. 764-774
INFECTION OF BABOONS WITH SIMIAN HUMAN IMMUNODEFICIENCY VIRUSES
Authors: ALLAN JS RAY P BROUSSARD S WHITEHEAD E HUBBARD G BUTLER T BRASKY K LUCIW P CHENGMAYER C LEVY JA STEIMER K LI J SODROSKI J GARCIAMOLL M
Citation: Js. Allan et al., INFECTION OF BABOONS WITH SIMIAN HUMAN IMMUNODEFICIENCY VIRUSES, Journal of acquired immune deficiency syndromes and human retrovirology, 9(5), 1995, pp. 429-441
ADENOVIRUS-HIV-1(MN) ENV RECOMBINANTS AND A SF2 GP120 BOOST PROTECT CHIMPANZEES FROM A SF2 CHALLENGE
Authors: ROBERTGUROFF M NATUK RJ MYAGKIKH M ALDRICH K ALIPANAH S KALYAN N MURTHY SCS WADE MS SINANGIL F STEIMER K NIGIDA SM ARTHUR LO MARKHAM PD GALLO RC EICHBERG JW LUBECK MD
Citation: M. Robertguroff et al., ADENOVIRUS-HIV-1(MN) ENV RECOMBINANTS AND A SF2 GP120 BOOST PROTECT CHIMPANZEES FROM A SF2 CHALLENGE, AIDS research and human retroviruses, 11, 1995, pp. 136-136
PRIMING OF CYTOTOXIC T-LYMPHOCYTE RESPONSES WITH RECOMBINANT HIV ENVELOPE PROTEINS IN MURINE AND PRIMATE MODELS
Authors: WALKER CM DOE B LIU YA VANNEST G STEIMER K
Citation: Cm. Walker et al., PRIMING OF CYTOTOXIC T-LYMPHOCYTE RESPONSES WITH RECOMBINANT HIV ENVELOPE PROTEINS IN MURINE AND PRIMATE MODELS, AIDS research and human retroviruses, 10, 1994, pp. 190000089-190000089
MICROFLUIDIZED OIL-EMULSIONS AS ADJUVANTS FOR HIV AND OTHER HUMAN VACCINES
Authors: VANNEST G WALKER C STEIMER K BAENZIGER J BURKE RL OTT G
Citation: G. Vannest et al., MICROFLUIDIZED OIL-EMULSIONS AS ADJUVANTS FOR HIV AND OTHER HUMAN VACCINES, AIDS research and human retroviruses, 10, 1994, pp. 190000115-190000115
AN AVEG PHASE-I RANDOMIZED, BLINDED, CONTROLLED TRIAL IN ASYMPTOMATICHIV-INFECTED SUBJECTS USING ENV-2-3 IN MF-59 WITH OR WITHOUT MTP-PE
Authors: COREY L MCELRATH MJ KEEFER M DOLIN R CHERNOFF D GREENBERG PD COOMBS R STEIMER K SPOSTO R
Citation: L. Corey et al., AN AVEG PHASE-I RANDOMIZED, BLINDED, CONTROLLED TRIAL IN ASYMPTOMATICHIV-INFECTED SUBJECTS USING ENV-2-3 IN MF-59 WITH OR WITHOUT MTP-PE, AIDS research and human retroviruses, 10, 1994, pp. 190000157-190000157
EVALUATION OF MONOCLONAL-ANTIBODIES TO HIV-1 ENVELOPE BY NEUTRALIZATION AND BINDING ASSAYS - AN INTERNATIONAL COLLABORATION
Authors: DSOUZA MP GEYER SJ HANSON CV HENDRY RM MILMAN G CHAMOW S FUNG M GEYER S HAIGWOOD N HANSON C HENDRY M HATTORI T HUISMAN H SCHUITEMAKER H KATINGER H KLIKS S LEVY J LAMAN J LANGEDIJK H MELOEN R MCPHEE D MITCHELL W NARA P PAGE M LING C PINTER A POSNER M POTTS B FIELD K RICHMAN D ROBINSON J STEIMER K STOTT J CORCORAN T THIRIART C WAHREN B WAINBERG M WEBER J ZOLLAPAZNER S BUCHINDER A
Citation: Mp. Dsouza et al., EVALUATION OF MONOCLONAL-ANTIBODIES TO HIV-1 ENVELOPE BY NEUTRALIZATION AND BINDING ASSAYS - AN INTERNATIONAL COLLABORATION, AIDS, 8(2), 1994, pp. 169-181
DETERMINATION OF THE INTEGRITY OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) GP120 BY GEL-PERMEATION HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY (HPLC)
Authors: SEID R TOMLINSON B COATES S PIGIET V STEIMER K HO S
Citation: R. Seid et al., DETERMINATION OF THE INTEGRITY OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) GP120 BY GEL-PERMEATION HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY (HPLC), The FASEB journal, 7(7), 1993, pp. 1253-1253
MONITORING GP120 STRUCTURAL INTEGRITY DURING FERMENTATION
Authors: TUCK SF COATES S STEIMER K PIGIET V SEID R
Citation: Sf. Tuck et al., MONITORING GP120 STRUCTURAL INTEGRITY DURING FERMENTATION, The FASEB journal, 7(7), 1993, pp. 1253-1253
OLIGOSACCHARIDE PROFILING OF GP120 USING THE FACE TECHNOLOGY
Authors: MCALISTER S TUCK SF STEIMER K PIGIET V SEID R STARR C
Citation: S. Mcalister et al., OLIGOSACCHARIDE PROFILING OF GP120 USING THE FACE TECHNOLOGY, The FASEB journal, 7(7), 1993, pp. 1253-1253
PRECLINICAL IMMUNOGENICITY STUDIES IN BABOONS WITH CANDIDATE HIV-1 SUBUNIT VACCINES PREDICT THE HUMAN IMMUNE-RESPONSE
Authors: STEIMER K BAENZIGER J KAHN J VANNEST G CHERNOFF D DEKKER C SINANGIL F
Citation: K. Steimer et al., PRECLINICAL IMMUNOGENICITY STUDIES IN BABOONS WITH CANDIDATE HIV-1 SUBUNIT VACCINES PREDICT THE HUMAN IMMUNE-RESPONSE, AIDS research and human retroviruses, 9, 1993, pp. 190000041-190000041
PHASE-1 DOSE-ESCALATION MTP-PE STUDY OF AN HIV-1 GP120 VACCINE IN SERONEGATIVE ADULTS
Authors: KAHN J CHERNOFF D SINANGIL F MURCAR N WYNNE D COLEMAN R STEIMER K DEKKER C
Citation: J. Kahn et al., PHASE-1 DOSE-ESCALATION MTP-PE STUDY OF AN HIV-1 GP120 VACCINE IN SERONEGATIVE ADULTS, AIDS research and human retroviruses, 9, 1993, pp. 190000112-190000112
PHASE-STUDY OF AN HIV-1 GP 120 VACCINE COMBINED WITH THE NOVEL ADJUVANT EMULSION, MF59 AND THE BIOLOGIC RESPONSE MODIFIER MTP-PE IN HIV SERONEGATIVE ADULTS
Authors: KAHN J CHERNOFF D SINANGIL F BAENZIGER J MURCAR N WYNNE D COLEMAN R STEIMER K DEKKER C
Citation: J. Kahn et al., PHASE-STUDY OF AN HIV-1 GP 120 VACCINE COMBINED WITH THE NOVEL ADJUVANT EMULSION, MF59 AND THE BIOLOGIC RESPONSE MODIFIER MTP-PE IN HIV SERONEGATIVE ADULTS, Journal of cellular biochemistry, 1993, pp. 79-79
AN IMPROVED METHOD FOR ASSESSING ANTIBODY-RESPONSES TO THE PRINCIPAL NEUTRALIZING DETERMINANT (PND) OF HIV-1 GP120
Authors: SAKAMOTO D BAENZIGER J SINANGIL F LEE D TURCK C STEIMER K
Citation: D. Sakamoto et al., AN IMPROVED METHOD FOR ASSESSING ANTIBODY-RESPONSES TO THE PRINCIPAL NEUTRALIZING DETERMINANT (PND) OF HIV-1 GP120, Journal of cellular biochemistry, 1993, pp. 85-85
MAPPING OF ANTIBODY-RESPONSES OF HIV-1 SERONEGATIVE INDIVIDUALS VACCINATED WITH RECOMBINANT HIV-SF2 GP120
Authors: SINANGIL F TRIBBICK G MASON T KAHN J CHERNOFF D STEIMER K
Citation: F. Sinangil et al., MAPPING OF ANTIBODY-RESPONSES OF HIV-1 SERONEGATIVE INDIVIDUALS VACCINATED WITH RECOMBINANT HIV-SF2 GP120, Journal of cellular biochemistry, 1993, pp. 86-86
EFFECTS OF HIVIG AND IVIG IN A MURINE MODEL WITH SUBSEQUENT IMMUNIZATION OF OFFSPRING
Authors: JELONEK MT STEIMER K CUMMINS L BRUST J KELLER M
Citation: Mt. Jelonek et al., EFFECTS OF HIVIG AND IVIG IN A MURINE MODEL WITH SUBSEQUENT IMMUNIZATION OF OFFSPRING, Journal of cellular biochemistry, 1993, pp. 97-97
Risultati: 1-19 |